Pharmacovigilance World on September 11-12, 2024 in London, United Kingdom

This conference will serve as a knowledge-sharing and networking platform, providing a unique opportunity for researchers, pharmacists, healthcare professionals, industry representatives, and regulatory authorities to come together and discuss the latest trends, challenges, and advancements in pharmacovigilance. By sharing experiences and best practices, we aim to enhance global drug safety and improve patient outcomes. Throughout the conference, we will delve into various topics such as signal detection and management, adverse event reporting and analysis, risk assessment, benefit-risk evaluation, regulatory updates, collaboration and the integration of artificial intelligence and digital technologies in pharmacovigilance.

Our esteemed panel of speakers, comprising leading experts from academia, industry, and regulatory agencies, will present their research findings, share case studies, and engage in thought-provoking discussions. The conference will also feature interactive networking opportunities, fostering collaboration and enabling the exchange of ideas.

We are delighted to welcome you to the Pharmacovigilance World 2024, and we are confident that your active participation will contribute to the advancement of drug safety practices. Together, let us strive towards a safer and more vigilant healthcare system that prioritizes patient well-being and ensures the continued benefit of medications worldwide.

Key Highlights:

Pharmacovigilance and globalization

Pharmacovigilance in a pandemic world

Women and child health care medicines and pharmacovigilance

Patient-centric approaches in PV

Pharmacovigilance legislation and regulations

Harmonization and pharmacovigilance

Advanced therapeutic techniques and pharmacovigilance

Pharmacovigilance and data management and eudravigilance

Post-marketing surveillance in pharmacovigilance

PV regulations and challenges

Benefit-risk management strategies

Risk management and minimization

Risk Evaluation and Mitigation

Adverse drug reactions reporting

Signal detection and post authorization safety

Good Pharmacovigilance Practices

Innovative approaches to drug safety

Strategies to improve PV

Real World Evidence in PV

Big data and AI in pharmacovigilance

Pharmacovigilance Workflows with AI & Automation

Other emerging technologies in PV

Who should attend the conference?

Attendees include GMs, VPs, Directors, Heads and Managers of:

Pharmacovigilance

Safety & Risk management

Drug safety

PV Compliance

Safety Surveillance

Medical Affairs

Regulatory Affairs

Inspection and Audit

Pharmacoepidemiology

Post-market studies

Medical product safety assessment

Drug Research & Development

Clinical Pharmacology

Medical information

Contract outsourcing service providers

Health outcomes

Sales and Marketing